Literature DB >> 18796388

Human Health Risk Assessment approach for urban park development.

Lalita Bharadwaj1, Ray Machibroda.   

Abstract

A Human Health Risk Assessment (HHRA) was undertaken for a proposed park development "River Landing", to be constructed along the north bank of the South Saskatchewan River in the City of Saskatoon, Saskatchewan, Canada. The purpose of the HHRA was to determine whether chemical constituents identified at the site, including polycyclic aromatic hydrocarbons (PAHs), petroleum hydrocarbons (PHCs), and toxic and heavy metals, would adversely affect the health of construction workers and potential park users. Although more traditional remediation options were considered, the risk assessment approach was chosen since it represented the best available technology. The HHRA was undertaken using protocols and methodologies proposed and readily accepted by the Canadian Council of Ministers of the Environment (CCME), Health Canada, and the United States Environmental Protection Agency (US EPA). Results of the risk assessment revealed that the magnitude and distribution of the chemicals at the site were such that extensive remediation was not required, and that the site could be developed without any significant restrictions on the proposed use. The assessment revealed that potential exposure to soil constituents would not result in adverse health risk to construction workers involved in park development or future park users.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18796388     DOI: 10.2478/10004-1254-59-2008-1882

Source DB:  PubMed          Journal:  Arh Hig Rada Toksikol        ISSN: 0004-1254            Impact factor:   1.948


  1 in total

1.  Chemometrics, health risk assessment and probable sources of soluble total petroleum hydrocarbons in atmospheric rainwater, Rivers State, Nigeria.

Authors:  Daniel Omeodisemi Omokpariola; John Kanayochukwu Nduka; Henrietta Ijeoma Kelle; Nkoli MaryAnn Mgbemena; Emily Osa Iduseri
Journal:  Sci Rep       Date:  2022-07-12       Impact factor: 4.996

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.